Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | 01/31/2019 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 34.90K | 25.50K | 33.60K | 167.10K | 86.80K |
Total Receivables | 2.40K | 1.80K | -- | 3.30K | 14.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 136.10K | 156.30K | 182.10K | 205.80K | 217.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 173.40K | 183.60K | 215.70K | 376.20K | 318.60K |
|
|||||
Total Current Assets | 173.40K | 183.60K | 215.70K | 376.20K | 318.60K |
Net Property, Plant & Equipment | 0.00 | 200.00 | 300.00 | 700.00 | 1.70K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 514.60K | 532.60K | 548.70K | 551.90K | 733.20K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 687.90K | 716.30K | 764.70K | 928.80K | 1.05M |
|
|||||
Total Accounts Payable | 1.24M | 1.47M | 1.47M | 1.45M | 1.46M |
Total Accrued Expenses | 365.30K | 304.20K | 333.50K | 195.00K | 164.60K |
Short-term Debt | 355.20K | 259.80K | 144.00K | 148.80K | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.67M | 1.25M | 975.80K | 920.30K | 533.50K |
Total Other Current Liabilities | 1.67M | 1.25M | 975.80K | 920.30K | 533.50K |
Total Current Liabilities | 3.64M | 3.28M | 2.92M | 2.71M | 2.16M |
|
|||||
Total Current Liabilities | 3.64M | 3.28M | 2.92M | 2.71M | 2.16M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 355.20K | 259.80K | 144.00K | 148.80K | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.64M | 3.28M | 2.92M | 2.71M | 2.16M |
|
|||||
Common Stock & APIC | 31.19M | 31.26M | 31.29M | 30.60M | 31.30M |
Retained Earnings | -34.84M | -34.61M | -34.24M | -33.09M | -33.11M |
Treasury Stock & Other | 694.10K | 784.40K | 794.40K | 708.00K | 707.70K |
Total Common Equity | -2.95M | -2.56M | -2.16M | -1.79M | -1.11M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.95M | -2.56M | -2.16M | -1.79M | -1.11M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.95M | -2.56M | -2.16M | -1.79M | -1.11M |
|